Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report
01. Pre-meeting Briefing
02. ERG report - Warwick Evidence
03. ERG group report - factual accuracy check
04. Manufacturer submission - Bayer
05. Manufacturer PAS Submission - Bayer
06. NICE request for clarification
07. Clarification response
08. Organisation submission - RNIB
09. Organisation submission - Royal College Of Opthalmologists
10. Expert personal perspective - CEaglen
11. Expert personal perspective - CYelf
12. Expert personal perspective - IPearce
13. Expert personal perspective - SSivaprasad
* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *
Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: evaluation report
08 January 2014 (5.51 Mb 22 sec) |
This page was last updated: 08 January 2014